Dechra Veterinary Products and ANOxA recently signed a license agreement for ANOxA’s patented technology designed to control Exercise Induced Pulmonary Hemorrhage, EIPHiSOL.

Developed by ANOxA, this new technology could provide performance horses with an effective treatment for Exercise Induced Pulmonary Hemorrhage. The license agreement allows Dechra to perform mandatory studies for regulatory filings and final government approvals of the product in the United States and other countries. Dechra also obtained granted rights to sell and distribute EIPHiSOL worldwide.

For more information, contact: Dechra Veterinary Products, 7015 College Blvd, Suite 525, Overland Park, KS 66211; 866/933-2472; www.dechra-us.com